DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Price CF, Tyssen D, Sonza S et al.
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.
PLoS One 2011;
6: e24095
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.